Your browser doesn't support javascript.
loading
Circulating biomarkers during treatment in patients with advanced biliary tract cancer receiving cediranib in the UK ABC-03 trial.
Backen, Alison C; Lopes, Andre; Wasan, Harpreet; Palmer, Daniel H; Duggan, Marian; Cunningham, David; Anthoney, Alan; Corrie, Pippa G; Madhusudan, Srinivasan; Maraveyas, Anthony; Ross, Paul J; Waters, Justin S; Steward, William P; Rees, Charlotte; McNamara, Mairéad G; Beare, Sandy; Bridgewater, John A; Dive, Caroline; Valle, Juan W.
Afiliación
  • Backen AC; Centre for Cancer Biomarker Sciences, Cancer Research UK Manchester Institute, Manchester, M20 4BX, UK.
  • Lopes A; Cancer Research UK & University College London Cancer Trials Center, London, W1T 4TJ, UK.
  • Wasan H; Hammersmith Hospital, Imperial College Healthcare Trust, London, W12 0HS, UK.
  • Palmer DH; Liverpool Experimental Cancer Medicine Centre, University of Liverpool Cancer Research UK Center, Liverpool, L69 3GL, UK.
  • Duggan M; Cancer Research UK & University College London Cancer Trials Center, London, W1T 4TJ, UK.
  • Cunningham D; The Royal Marsden, London, SW3 6JJ & Surrey SM2 5PT, UK.
  • Anthoney A; Leeds Cancer Research UK Clinical Center, Leeds, LS2 9JT, UK.
  • Corrie PG; Cambridge Cancer Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB2 0QQ, UK.
  • Madhusudan S; Division of Cancer & Stem Cells, University of Nottingham, Nottingham University Hospitals, Nottingham, NG7 2UH, UK.
  • Maraveyas A; Castle Hill Hospital, Hull, HU16 5JQ, UK.
  • Ross PJ; Department of Oncology, King's College Hospital, London, SE5 9RS, UK.
  • Waters JS; Kent Oncology Center, Maidstone, ME16 9QQ, UK.
  • Steward WP; Leicester Royal Infirmary, Leicester, LE1 5WW, UK.
  • Rees C; University Hospital Southampton NHS Foundation Trust, Southampton, SO16 6YD, UK.
  • McNamara MG; Hampshire Hospitals NHS Foundation Trust, Basingstoke, RG24 9NA, UK.
  • Beare S; Division of Cancer Sciences, University of Manchester, Manchester, M13 9PL, UK.
  • Bridgewater JA; The Christie NHS Foundation Trust, Manchester, M20 4BX, UK.
  • Dive C; Cancer Research UK & University College London Cancer Trials Center, London, W1T 4TJ, UK.
  • Valle JW; UCL Cancer Institute, London, WC1E 6DD, UK.
Br J Cancer ; 119(1): 27-35, 2018 07.
Article en En | MEDLINE | ID: mdl-29925934
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias del Sistema Biliar / Receptor 2 de Factores de Crecimiento Endotelial Vascular / Factor A de Crecimiento Endotelial Vascular / Queratina-18 Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Br J Cancer Año: 2018 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias del Sistema Biliar / Receptor 2 de Factores de Crecimiento Endotelial Vascular / Factor A de Crecimiento Endotelial Vascular / Queratina-18 Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Br J Cancer Año: 2018 Tipo del documento: Article País de afiliación: Reino Unido